The A3 adenosine receptor: An enigmatic player in cell biology

Pharmacology and Therapeutics

Volumn 117, Issue 1, 2008, Pages 123-140

  Gessi, Stefania ^a   Merighi, Stefania ^a   Varani, Katia ^a   Leung, Edward ^b   Mac Lennan, Stephen ^b   Borea, Pier Andrea ^a  

^a Interdisciplinary Center for the Study of Inflammation   (Italy)

^b King Pharmaceuticals   (United States)

Author keywords

Adenosine A3 receptor; Cancer; Gene and tissue localization; Inflammation; Ischemic conditions

Indexed keywords

ADENOSINE A3 RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; LIGAND;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CARDIOTOXICITY; CYTOLOGY; GENE LOCATION; GENE STRUCTURE; HEART PROTECTION; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; MOLECULAR CLONING; NEUROPROTECTION; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; IMMUNE SYSTEM; INFLAMMATION; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; REPERFUSION INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LIGANDS; MYOCARDIAL REPERFUSION INJURY; NEOPLASMS; RECEPTOR, ADENOSINE A3; SIGNAL TRANSDUCTION;

EID: 36549081419     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.09.002     Document Type: Review

References (193)

1. 3 receptors in rat brain. Mol Pharmacol 48 (1995) 1038-1045
2. 3 adenosine receptor induces cytoskeleton rearrangement in human astrocytoma cells via a specific action on Rho proteins. Ann N Y Acad Sci 939 (2001) 63-73
3. 3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells. Biochem Biophys Res Communun 241 (1997) 297-304
4. Adair T.H. Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 289 (2005) R283-R296
5. 3 receptor-induced apoptosis. J Mol Neurosci 17 (2001) 285-292
6. 3 receptor (ADORA3) gene. Neurosci Res 29 (1997) 73-79
7. 6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80 (1997) 800-809
8. 2B receptor. Mol Pharmacol 52 (1997) 846-860
9. 3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 285 (2003) H607-H613
10. 3 adenosine receptor agonists in murine autoimmune arthritis models. J Rheumatol 32 (2005) 469-476
11. Barbieri D., Abbracchio M.P., Salvioli S., Monti D., Cossarizza A., Ceruti S., et al. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem Int 32 (1998) 493-504
12. 3 adenosine receptor induce G-CSF production via NF-κB activation: a new class of nyeloprotective agents. Exp Hematol 30 (2002) 1390-1398
13. 3 adenosine receptor. Circ Res 91 (2002) 165-172
14. Blay J., White T.D., and Hoskin D.W. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 57 (1997) 2602-2605
15. Bouma M.G., Jeuhomme T.M.M.A., Boyle D.L., Dentener M.A., Voitenok N.N., van den Wildenberg F.A.J.M., et al. Adenosine inhibits neutrophil degranulation in activated human whole blood. J Immunol 158 (1997) 5400-5408
16. 3 receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 40 (2001) 85-95
17. 3 receptor. J Vet Pharmacol Ther 29 (2006) 255-263
18. 3 adenosine receptor. J Leukoc Biol 66 (1999) 495-501
19. 3 adenosine receptor. Thromb Haemost 88 (2002) 123-130
20. Butler J.J., Mader J.S., Watson C.L., Zhang H., Blay J., and Hoskin D.W. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. J Cell Biochem 89 (2003) 975-991
21. 3 receptors: two into one won't go. Trends Pharmacol Sci 14 (1993) 290-291
22. 3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. Am J Physiol Heart Circ Physiol 281 (2001) H1751-H1758
23. 3 receptors. Science 314 (2006) 1792-1795
24. 3 receptors reduces ischemic brain injury in rodents. J Neurosci Res 84 (2006) 1848-1855
25. 3 receptors in the human enteric nervous system. J Comp Neurol 439 (2001) 46-64
26. 3 adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol 283 (2002) H1562-H1568
27. 3 receptor activation. Am J Physiol Heart Circ Physiol 288 (2005) H328-H335
28. 3 receptor by Akt-dependent and independent pathway. J Pharmacol Exp Ther 314 (2005) 762-769
29. 3 receptors in the mouse dendritic cell line XS-106. Eur J Pharmacol 474 (2003) 43-51
30. Di Iorio P., Kleywegt S., Ciccarelli R., Traversa U., Andrew C.M., Crocker C.E., et al. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 38 (2002) 179-190
31. 3 receptor subtypes in rat pial and intracerebral arteries. Neurosci Lett 366 (2004) 48-52
32. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J.S., Richardson P.J., and Freeman T.C. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118 (1996) 1461-1468
33. 1 receptor-mediated responses in rat hippocampus. J Neurosci 17 (1997) 607-614
34. El-Hashim A., D'Agostino B., Matera M.G., and Page C. Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br J Pharmacol 119 (1996) 1262-1268
35. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
36. 3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol 127 (1999) 188-194
37. 3 adenosine receptor: sensitivity to hypoxic neurodegeneration. Cell Mol Neurobiol 23 (2003) 431-447
38. 2B receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96 (1995) 1979-1986
39. 3 adenosine receptors. Circ Res 92 (2003) 485-492
40. 3AR agonist. Anticancer Res 23 (2003) 2077-2083
41. 3 adenosine receptor as a target for cancer therapy. Anticancer Drugs 13 (2002) 1-8
42. Fishman P., Bar-Yehuda S., Madi L., Rath-Wolfson L., Ochaion A., Cohen S., et al. The PI3K-NF-κB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Res Ther 8 (2006) R33
43. 3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3β and NF-κB. Oncogene 23 (2004) 2465-2471
44. 3 adenosine receptor. Eur J Cancer 36 (2000) 1452-1458
45. Fishman P., Bar-Yehuda S., and Vagman L. Adenosine, other low molecular wheight factors released by muscle cells inhibit tumor cell growth: possible explanation for the rarity of metastases in muscle. Cancer Res 58 (1998) 3181-3187
46. 3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells. Mol Pharmacol 63 (2003) 342-350
47. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol 109 (1993) 3-5
48. 3 receptor activation in rats. Eur J Pharmacol 298 (1996) 293-297
49. Fredholm B.B. Adenosine receptors as targets for drug development. Drug News Perspect 16 (2003) 283-289
50. Fredholm B.B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14 (2007) 1315-1323
51. 3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol 59 (2001) 76-82
52. 3 adenosine receptor. J Pharmacol Exp Ther 319 (2006) 1200-1210
53. Germack R., and Dickenson J.M. Characterization of ERK 1/2 signaling pathways induced by adenosine receptor subtype in newborn rat cardiomyocytes. Br J Pharmacol 141 (2004) 329-339
54. Germack R., and Dickenson J.M. Adenosine triggers preconditioning through MEK/ERK1/2 signaling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes. J Mol Cell Cardiol 39 (2005) 429-442
55. 3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol Pharmacol 61 (2002) 415-424
56. 3 adenosine receptors in Jurkat T cells. Br J Pharmacol 134 (2001) 116-126
57. 3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res 10 (2004) 5895-5901
58. 3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol Pharmacol 65 (2004) 711-719
59. 3 adenosine subtype. J Cell Physiol 211 (2007) 826-836
60. 3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. J Mol Cell Cardiol 33 (2001) 825-830
61. 3 receptors in microglia cells. J Neurochem 86 (2003) 1051-1054
62. 3 receptor-mediated hypotension in the rat. Br J Pharmacol 115 (1995) 945-952
63. 3 adenosine receptor agonist potentiates natural killer cell activity. Int J Oncol 23 (2003) 1245-1249
64. 3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart. Cardiovasc Res 53 (2002) 147-155
65. 3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice. Eur J Pharmacol 358 (1998) 261-268
66. Haskó G., Pacher P., Vizi E.S., and Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 26 (2005) 511-516
67. Haskó G., Pacher P., Deitch E.A., and Vizi E.S. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 113 (2007) 264-275
68. 3 adenosine receptor-mediated protection of the ischemic heart. Vascul Pharmacol 42 (2005) 271-279
69. 3 receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons. Restor Neurol Neurosci 21 (2003) 55-63
70. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93 (2001) 266-276
71. Hofer S., Ivarsson L., Stoitzner P., Auffinger M., Rainer C., Romani N., et al. Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J Invest Dermatol 121 (2003) 300-307
72. Hopfl G., Ogunshola O., and Gassmann M. HIFs and tumors-causes and consequences. Am J Physiol Regul Integr Comp Physiol 286 (2004) R608-R623
73. Hoskin D.W., Reynolds T., and Blay J. Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell induction. Cancer Immunol Immunother 38 (1994) 201-207
74. Hoskin D.W., Reynolds T., and Blay J. Adenosine as a possible inhibitor of killer T-cell activation in the microenvironment of solid tumours. Int J Cancer 59 (1994) 854-855
75. 2 cell-surface adenosine receptor. Cell Immunol 159 (1994) 85-93
76. 3 receptor to prevent the induction of murine anti-CD3-activated killer T cells. Int J Cancer 99 (2002) 386-395
77. 3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci 19 (1998) 184-191
78. Jacobson K.A., and Gao Z.-G. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5 (2006) 247-264
79. 3-adenosine receptors: mediation of behavioural depressant effects. FEBS Lett 336 (1993) 57-60
80. 3-adenosine receptors. Drug Dev Res 33 (1994) 51-59
81. 3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol 277 (1999) H1895-H1905
82. 3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 88 (1996) 3569
83. 3 receptor agonists. Biochem Biophys Res Commun 219 (1996) 904-910
84. Kin H., Zatta A.J., Lofye M.T., Amerson B.S., Halkos M.E., Kerendi F., et al. Postconditionning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67 (2005) 124-133
85. 3 adenosine receptor. J Pharmacol Exp Ther 317 (2006) 172-180
86. la Sala A., Gadina M., and Kelsall B.L. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J Immunol 175 (2005) 2994-2999
87. 3 adenosine receptor agonist 2-CL-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices. Epilepsy Res 59 (2004) 83-94
88. 3 receptors. Am J Physiol Renal Physiol 278 (2000) F380-F387
89. Lee J.E., Bokoch G., and Liang B. A novel cardioprotective role of RhoA: new signaling mechanism for adenosine. FASEB J 15 (2001) 1886-1894
90. 3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure. Am J Physiol Renal Physiol 284 (2003) F267-F273
91. 3 receptor suppresses lipopolysaccaride-induced TNF-α production through inhibition of PI-3-kinase/Akt and NF-κB activation in murine BV2 microglial cells. Neurosci Lett 396 (2006) 1-6
92. 3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. Am J Physiol Regul Integr Comp Physiol 291 (2006) R959-R969
93. Le Vraux V., Chen Y., Masson I., DeSousa M., Giroud J., Florentin I., et al. Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 52 (1993) 1971
94. 3 receptors in cortical neurons: pharmacological aspects and neuroprotection during hypoxia. Drug Dev Res 58 (2003) 420-427
95. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15 (1994) 298-306
96. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41 (2001) 775-787
97. Linden J. Purinergic chemotaxis. Science 314 (2006) 1689-1690
98. 3 adenosine receptor with widespread tissue distribution. Mol Pharmacol 44 (1993) 524-532
99. 3 receptors are located in neurons of the rat hippocampus. Neuroreport 14 (2003) 1645-1648
100. 1 receptors. Drug Dev Res 58 (2003) 428-438
101. Lu J., Pierron A., and Ravid K. An adenosine analogue, IB-MECA, down-regulates estrogen receptor α and suppresses human breast cancer cell proliferation. Cancer Res 63 (2003) 6413-6423
102. 6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis. Eur J Pharmacol 466 (2003) 323-329
103. 3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J Neurosci 18 (1998) 6138-6146
104. 3 receptor. Cancer Res 54 (1994) 3521-3526
105. 7 integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells. Exp Cell Res 276 (2002) 90-100
106. 3 receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am J Physiol Heart Circ Physiol 283 (2002) H1307-H1313
107. 3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level. J Rheumatol 34 (2007) 20-26
108. 3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10 (2004) 4472-4479
109. 3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-α release by reducing calcium-dependent activation of nuclear factor-kB and extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 316 (2006) 71-78
110. 3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion. Crit Care 10 (2006) R65
111. 3 receptors on macrophages inhibits tumor necrosis factor-α. Eur J Pharmacol 310 (1996) 209-216
112. Merighi S., Mirandola P., Varani K., Gessi S., Leung E., Baraldi P.G., et al. A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol Ther 100 (2003) 31-48
113. Merighi S., Varani K., Gessi S., Cattabriga E., Iannotta V., Ulouglu C., et al. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375. Br J Pharmacol 134 (2001) 1215-1226
114. 3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells. J Biol Chem 280 (2005) 19516-19526
115. 3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells. Neoplasia 10 (2005) 894-903
116. Merighi S., Benini A., Mirandola P., Gessi S., Varani K., Leung E., et al. Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells. Biochem Pharmacol 72 (2006) 19-31
117. Merighi S., Benini A., Mirandola P., Gessi S., Varani K., Leung E., et al. Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of BAD in glioblastoma cells. Mol Pharmacol 72 (2007) 162-172
118. Merighi S., Benini A., Mirandola P., Gessi S., Varani K., Simioni C., et al. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 72 (2007) 395-406
119. Meyerhof W., Müller-Brechlin R., and Richter D. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett 284 (1991) 155-160
120. Minchenko A., Leshchinsky I., Opentanova I., Sang N., Srinivas V., Armstead V., et al. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 277 (2002) 6183-6187
121. -channels of nonpigmented ciliary epithelial cell. Am J Physiol 276 (1999) C659-C666
122. Mozzicato S., Joshi B.V., Jacobson K.A., and Liang B.T. Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia. FASEB J 18 (2004) 406-408
123. 3 receptor gene. FEBS Lett 384 (1996) 243-246
124. Nakai Y., Horimoto H., Mieno S., and Sasaki S. Mitochondrial ATP-sensitive potassium channel plays a dominant role in ischemic preconditionning of rabbit heart. Eur Surg Res 33 (2001) 57-63
125. 3 receptor stimulation. Anticancer Res 26 (2006) 43-47
126. 3 receptor ligands. Bioorg Med Chem Lett 14 (2004) 3775-3779
127. 2A adenosine receptor activation in PC12 pheochromocytoma cells. J Pharmacol Exp Ther 293 (2000) 779-787
128. 3 adenosine receptor. Mol Pharmacol 45 (1994) 978-982
129. 3 adenosine receptor. Mol Pharmacol 57 (2000) 539-545
130. 3 adenosine receptor. J Biol Chem 49 (1995) 29607-29613
131. Panjehpour M., and Karami-Tehrani F. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines. Int J Biochem Cell Biol 36 (2004) 1502-1509
132. Panther E., Idzko M., Herouy Y., Rheinen H., Geboicke-Haerter P.J., Mrowietz U., et al. Expression and function of adenosine receptors in human dendritic cells. FASEB J 15 (2001) 1963-1970
133. 6-(3-iodobenzyl)-adenosine-5′-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3β. J Pharmacol Exp Ther 318 (2006) 124-131
134. Parsons M., Young L., Lee J.E., Jacobson K.A., and Liang B.T. Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J 14 (2000) 1423-1431
135. Peart J.N., and Headrick J.P. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 114 (2007) 208-221
136. 3 receptor antagonist with therapeutic potential. Bioorg Med Chem Lett 15 (2005) 3081-3085
137. 3 adenosine receptors is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268 (1993) 16887-16890
138. Raskovalova T., Huang X., Sitkovsky M., Zacharia L.C., Jackson E.K., and Gorelik E. Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells. J Immunol 175 (2005) 4383-4391
139. 3 receptors in controlling kainite-induced toxicity in cortical cultured neurons. Neurochem Int 47 (2005) 317-325
140. 3 receptor stimulation on human eosinophils isolated from non-asthmatic or asthmatic donors. Inflamm Res 49 (2000) 666-672
141. 3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm Res 46 (1997) 180-184
142. 3 adenosine receptor induces calcium entry and chloride secretion in A6 cells. J Membr Biol 178 (2000) 103-113
143. Rimmer J., Peake H.L., Santos C.M.C., Lean M., Bardin P., Robson R., et al. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 37 (2007) 8-14
144. Rivkees S.A. Localization and characterization of adenosine receptor expression in rat testis. Endocrinology 135 (1994) 2307-2313
145. 3 adenosine receptors expressed in the brain?. Neuroreport 11 (2000) 1025-1030
146. 2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 172 (2004) 7726-7733
147. 3 receptors. J Immunol 156 (1996) 3435-3442
148. 3 adenosine receptor. Proc Natl Acad Sci U S A 90 (1993) 10365-10369
149. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275 (2000) 4429-4434
150. Sato T., Sasaki N., O'Rourke B., and Marban E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning?. Circulation 102 (2000) 800-805
151. 3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma. Invest Ophthalmol Vis Sci 46 (2005) 2023-2034
152. 3 receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol 58 (2000) 477-482
153. 3 receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol 62 (2002) 1137-1146
154. 3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons. Drug Dev Res 40 (1997) 267-273
155. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88 (2000) 1474-1480
156. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
157. 3 adenosine receptor agonist. Exp Cell Res 243 (1998) 383-397
158. 3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury. Am J Physiol Heart Circ Physiol 200 (2005) H2792-H2801
159. 3 adenosine receptor protects against doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol 33 (2001) 1249-1261
160. 3 adenosine receptor in cultured newborn rat cardiac myocytes. Cell Calcium 36 (2004) 387-396
161. 2A receptors. Annu Rev Immunol 22 (2004) 657-682
162. 3 receptors mediate rapid inflammatory cell influx into the lungs of sensitized guinea-pigs. Clin Exp Allergy 31 (2001) 943-951
163. Suh B.C., Kim T.D., Lee J.U., Seong J.K., and Kim K.T. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. Br J Pharmacol 134 (2001) 132-142
164. Szabo C., Scott G.S., Virag L., Egnaczyk G., Salzman A.L., Shanley T.P., et al. Suppression of macrophage inflammatory protein (MIP)-1a production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 125 (1998) 379-387
165. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88 (2001) 520-528
166. Thiele A., Kronstein R., Wetzel A., Gerth A., Nieber K., and Hauschildt S. Regulation of adenosine receptor subtypes during cultivation of human monocytes: role of receptors in preventing lipopolysaccharide-triggered respiratory burst. Infect Immun 72 (2004) 1349-1357
167. 3 pretreatment before cardioplegic arrest attenuates postischemic cardiac dysfunction. Ann Thorac Surg 67 (1999) 1732-1737
168. ATP channels. Am J Physiol 46 (1999) H228-H235
169. 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc Res 33 (1997) 410-415
170. 3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol Pharmacol 62 (2002) 1373-1384
171. 3 adenosine receptor regulation. Biochim Biophys Acta 1591 (2002) 55-62
172. Varani K., Caramori G., Vincenti F., Adcock I., Casolari P., Leung E., et al. Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 (2006) 398-406
173. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49 (1989) 6449-6465
174. Von Lubitz D.K.J.E. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?. Eur J Pharmacol 371 (1999) 85-102
175. 3 receptor agonist and cerebral ischemia: neuronal and glial effects. Eur J Pharmacol 367 (1999) 157-163
176. 3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263 (1994) 59-67
177. 3 receptors and cerebroprotection in stroke. Ann N Y Acad Sci 939 11 (2001) 85-96
178. 3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 16 (1997) 531-537
179. Welsh S.J., and Powis G. Hypoxia inducible factor as a cancer drug target. Curr Cancer Drug Targets 3 (2003) 391-405
180. 3 adenosine receptor. Br J Pharmacol 140 (2003) 1009-1018
181. Wiener C.M., Booth G., and Semenza G.L. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225 (1996) 485-488
182. 3 receptor-induced CCl2 synthesis in cultured mouse astrocytes. Glia 46 (2004) 410-418
183. Wolber C., and Fozard J.R. The receptor mechanism mediating the contractile response to adenosine on lung parenchymal strips from actively sensitised, allergen-challenged Brown Norway rats. Naunyn Schmiedebergs Arch Pharmacol 371 (2005) 158-168
184. Xu Z., Jang Y., Mueller R.A., and Norfleet E.A. IB-MECA and cardioprotection. Cardiovasc Drug Rev 24 (2006) 227-238
185. 3 adenosine receptor gene promoter in transgenic mice: characterization of previously unidentified sites of expression. FEBS Lett 532 (2002) 267-272
186. 3 antagonists. Biochem Biophys Res Commun 232 (1997) 317-322
187. 3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173 (2004) 1380-1389
188. 2B receptors in the regulation of TNF-α production by human monocytes. Biochem Pharmacol 69 (2005) 883-889
189. 3 adenosine receptors prevent loss following P2X7 receptor stimulation. J Neurochem 98 (2006) 566-575
190. ATP channel. J Mol Cell Cardiol 34 (2002) 263-277
191. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59 (1999) 5830-5835
192. 3 receptor. J Immunol 170 (2003) 338-345
193. 3 adenosine receptor. Proc Natl Acad Sci U S A 89 (1992) 7432-7436